当前位置: 首页 > 期刊 > 《现代养生·下半月》 > 2018年第9期
编号:13337676
尿路上皮癌干细胞及细胞表面特征性分子标记的研究进展(2)
http://www.100md.com 2018年9月1日 《现代养生·下半月》 2018年第9期
     [3]Cheng L, Jones TD, McCarthy RP,Eble JN, Wang M, MacLennan GT, etal. Molecular genetic evidence foracommonclonal origin of urinarybladder small cell carcinoma andcoexisting urothelial carcinoma.Am J Pathol 2005; 166: 1533-9.

    [4]McConkey DJ, Lee S, Choi W, TranM, Majewski T, Lee S, et al.Molecular genetics of bladdercancer: emerging mechanisms oftumor initiation and progression.Urol Oncol 2010; 28: 429-40.

    [5]Vishnu P, Mathew J, Tan WW.Current therapeutic strategiesfor invasive and Metastaticbladder cancer. Onco Targets Ther2011; 4: 97-113.

    [6]Castillo-Martin M, Domingo-Domenech J, Karni-Schmidt O,Matos T, Cordon-Cardo C. Molecularpathways of urothelial developmentand bladder tumorigenesis. UrolOncol 2010; 28: 401-8.

    [7]Jebar AH, Hurst CD, Tomlinson DC,Johnston C, Taylor CF, Knowles MA.FGFR3 and Ras gene mutations aremutually exclusive genetic eventsin urothelial cell carcinoma.Oncogene, 2005; 24: 5218-25.

    [8]Chan KS, Espinosa I, Chao M,Wong D, Ailles L, Diehn M, etal. Identification, molecularcharacterization, clinicalprognosis, and therapeutictargeting of human bladder tumor-initiating cells. Proc Natl AcadSci U S A 2009;106:14016-21., 百拇医药(姜锡男 顾昌世 钟思文 李登宝 石家齐 孙发)
上一页1 2